Proactiveinvestors USA & Canada Redfund Capital Corp. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Redfund Capital Corp. RSS feed en Sun, 19 May 2019 19:45:38 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Redfund Capital to launch Dr Klein CBD brand ]]> https://www.proactiveinvestors.com/companies/news/220137/redfund-capital-to-launch-dr-klein-cbd-brand-220137.html Redfund Capital Corp (CSE:LOAN) (FRA:O3X4) (OTC:PNNRF) is launching a line of pharma-grade cannabidiol nutraceuticals headed by Robert Klein.

The Dr. Klein CBD brand includes a pain cream, healing stick, face moisturizer, infused serum and CBD-infused bath bombs.

The company plans to initially target the US chiropractic community, of which Klein is a member, through online consumer marketing before launching globally in the fall.

READ: Redfund Capital to fund Cannamerx cannabis exchange

“We are pleased to support Dr. Klein and the launch of the Dr. Klein CBD brand of pharma-grade CBD topicals and infused bathing products,” CEO Meris Kolt said. “These products will be laboratory tested prior to sales. We look forward to launching the Dr. Klein brand into Europe, South America and into Canada when regulation allows in the fall of 2019.”

Klein has been the chiropractor for Florida Atlantic University for 15 years and serves on the board of the Florida Chiropractic Association. He earned his doctorate from the National College of Chiropractic in Lombard, Illinois.

Redfund Capital provides debt and equity funding to companies in the medical cannabis community. The company will own an equity stake in Dr. Klein CBD.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

]]>
Mon, 13 May 2019 07:59:00 -0400 https://www.proactiveinvestors.com/companies/news/220137/redfund-capital-to-launch-dr-klein-cbd-brand-220137.html
<![CDATA[News - Redfund Capital to fund Cannamerx cannabis exchange ]]> https://www.proactiveinvestors.com/companies/news/219576/redfund-capital-to-fund-cannamerx-cannabis-exchange-219576.html Redfund Capital Corp (CSE:LOAN) (FRA:O3X4) (OTC:PNNRF) is putting its money into the Cannabis Mercantile Exchange, the company announced Tuesday.

The cannabis-centric investing firm signed a C$1.5 million two-year convertible promissory note to fund the exchange, known as Cannamerx. The exchange serves as a fully automated international business-to-business auction platform for cannabis, hemp and hemp products.

Since it went live in June, Cannamerx has auctioned nearly 25,000 kilograms of dried flower and its equivalents. Redfund hopes to goose its global expansion.

READ: Redfund Capital to start trading on US exchange

“Cannamerx has increased their client-base almost 30% since our first meetings in March 2019; 57 clients to over 80,” CEO Meris Kott said. “They have added hemp biomass and hemp products and the new automated spot auction ability for their traders, making it the go-to global cannabis exchange. Redfund’s focus has been to align ourselves with trailblazers in the sector and help incubate and accelerate and advise our portfolio clients as they build their valuations and grow their revenues.”

Redfund provides debt and equity funding to support developing or already developed companies, primarily in the cannabis sector.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

]]>
Thu, 02 May 2019 08:06:00 -0400 https://www.proactiveinvestors.com/companies/news/219576/redfund-capital-to-fund-cannamerx-cannabis-exchange-219576.html
<![CDATA[News - Redfund Capital to start trading on US exchange ]]> https://www.proactiveinvestors.com/companies/news/219378/redfund-capital-to-start-trading-on-us-exchange-219378.html Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF) announced Tuesday that it is listing its shares on the OTCQB exchange to broaden the company’s investor base in the US.

The cannabis merchant bank will trade under the ticker symbol “PNNRF.” It will continue to trade on the Canadian Securities Exchange as well as the Frankfurt Exchange.

"The listing of Redfund’s common stock to the OTCQB Exchange is an exciting milestone,” said Meris Kott, CEO of Redfund in a statement. “Even though Redfund has been a fully reporting company since its inception and listing to the Canadian Securities Exchange, or CSE, we believe that the broader exposure afforded by the OTCQB will raise our visibility within the US investment community and assist in increasing the liquidity of our common stock.”

READ: Redfund Capital provides $1M in financing to fund Cannaki Beverage

The Vancouver-based company provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

The company recently announced a C$1 million investment into infused beverage company Cannaki Beverage Inc

Shares of Redfund were up 3.5% at C$0.15 in Canada on Tuesday midday.

--Updates share price--

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

]]>
Tue, 30 Apr 2019 09:09:00 -0400 https://www.proactiveinvestors.com/companies/news/219378/redfund-capital-to-start-trading-on-us-exchange-219378.html
<![CDATA[News - RedFund Capital bolsters global reach with new director ]]> https://www.proactiveinvestors.com/companies/news/218449/redfund-capital-bolsters-global-reach-with-new-director-218449.html Redfund Capital Corp (CSE:LOAN) (OTC:PNNRF), the cannabis-focused investment firm, announced that it has Lindsey R. Perry Jr. as a director of the company as it continues on its global expansion. 

Perry has a wide range of experience with a significant background as a disciplined entrepreneur and business owner. 

"His team spirit, competitiveness, enthusiasm and financial prowess will be a huge asset to Redfund Capital as the company expands globally," noted the company in a release.

READ: Redfund Capital provides $1M in financing to fund Cannaki Beverage

Perry was born and raised in New England and relocated to south Florida from Nantucket in 2005. His family is credited as being one of the pioneering families to develop the Island of Nantucket as a vacation destination and after 2010, when Perry sold his business, the Tristram's Group Inc, to retire, he has continued investing in numerous private and public entities. 

He graduated from Bucknell University in 1977 with a bachelor of science degree majoring in accounting, and played collegiate hockey and golf for the NCAA Bucknell Bisons.

Redfund provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

Shares of Redfund were at C$0.17 on Thursday. 

Contact Katie Lewis at katie@proactiveinvestors.com

]]>
Thu, 11 Apr 2019 18:26:00 -0400 https://www.proactiveinvestors.com/companies/news/218449/redfund-capital-bolsters-global-reach-with-new-director-218449.html
<![CDATA[News - Redfund Capital provides $1M in financing to fund Cannaki Beverage ]]> https://www.proactiveinvestors.com/companies/news/217422/redfund-capital-provides-1m-in-financing-to-fund-cannaki-beverage-217422.html Redfund Capital Corp (CSE:LOAN) (OTC:PNNRF), the cannabis-focused investment firm, told investors Thursday that it will provide financing of about US $1 million to Cannaki Beverage Inc to help fund the beverage company’s expansion.

Under the deal’s terms, Vancouver-based Redfund and Cannaki, which is headquartered in Las Vegas, Nevada, signed a 2-year convertible note this week for $1 million at a yearly interest rate of 14%.

READ: Redfund Capital to fund CBD water company Cannaki Beverage

In a statement, Redfund CEO Meris Kott said Redfund would help Cannaki strike a deal with a licensed Canadian cannabis producer and get its CBD beverages on shelves in Canada.

“Cannaki has a strong network in the US, Mexico and Europe and they are planning to expand their products’ reach to Asia and South America,” Kott said. “Welcoming a beverage company with a strong experienced team to the portfolio is very exciting for Redfund and our beverage division.”

READ: Redfund Capital launches new drinks products division, shares jump

Cannaki makes both still and carbonated beverages, as well as Nano CBD-infused flavored water and hemp water.

The two-year note can be converted at Redfund’s discretion at any time during the term. In exchange, Cannaki will grant Redfund warrants in its common stock, equal to 20% of the amount of the note.

Redfund provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

Redfund shares slipped by less than C$0.01 to hit at C$0.15 in Canadian trade on Thursday.

Contact Ellen Kelleher at ellen@proactiveinvestors.com

-- This story is updated to reflect latest share price movement --

]]>
Thu, 28 Mar 2019 07:59:00 -0400 https://www.proactiveinvestors.com/companies/news/217422/redfund-capital-provides-1m-in-financing-to-fund-cannaki-beverage-217422.html
<![CDATA[Media files - Redfund Capital partner Cannamerx International launches Hemp/CBD Auction Platform ]]> https://www.proactiveinvestors.com/companies/stocktube/12683/redfund-capital-partner-cannamerx-international-launches-hempcbd-auction-platform-12683.html Thu, 21 Mar 2019 12:27:00 -0400 https://www.proactiveinvestors.com/companies/stocktube/12683/redfund-capital-partner-cannamerx-international-launches-hempcbd-auction-platform-12683.html <![CDATA[News - Redfund announces launch of Cannamerx International Hemp/CBD Auction Platform ]]> https://www.proactiveinvestors.com/companies/news/216947/redfund-announces-launch-of-cannamerx-international-hempcbd-auction-platform-216947.html Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF) announced Thursday the launch of the Cannabis Mercantile Exchange International Hemp/CBD Auction Platform.

Building on the success of its existing cannabis trading platform, Cannamerx reported 1.5 tonnes of hemp biomass has been listed for auction. Earlier this week, Redfund said it had formed a strategic alliance with Cannamerx to help it with financing and building clientele.

Cannamerx, according to Redfund, is welcoming hemp clients in Canada, the US and Europe and is in the process of vetting cannabidiol (CBD) labs in the US for trade there.

READ: Redfund announces strategic alliance with hemp auction platform Cannamerx

“The hemp revolution has begun in North America,” Redfund CEO Meris Kott said in a statement. “We are excited to help Cannamerx create a global path for many of these companies to trade Hemp/CBD internationally and become cash-flow-positive at a much quicker pace.”

By next fall, Kott is hopeful that CBD edibles will be federally approved and licensed in Canada, with Cannamerx’s platform providing the raw materials.

Redfund, based in Vancouver, provides debt and equity funding in the middle to late stages of a company’s development.

“We look forward to working with Redfund to roll out our platform and services for markets outside North America,” said Dietwald Claus, founder and CEO of Cannamerx.

Shares of Redfund slipped C$0.03 to C$0.20 in Wednesday’s Canadian trading. They traded at US$0.17 on the OTC Markets.

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Thu, 21 Mar 2019 08:33:00 -0400 https://www.proactiveinvestors.com/companies/news/216947/redfund-announces-launch-of-cannamerx-international-hempcbd-auction-platform-216947.html
<![CDATA[News - Redfund announces strategic alliance with hemp auction platform Cannamerx ]]> https://www.proactiveinvestors.com/companies/news/216846/redfund-announces-strategic-alliance-with-hemp-auction-platform-cannamerx-216846.html Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF) said Wednesday that it has formed a strategic alliance with Cannabis Mercantile Exchange, a hemp auction platform.

The cannabis-focused financier said it will help the company, also known as Cannamerx, with financing and building clientele. Redfund plans to publish terms of the deal next week

Cannamerx, according to Vancouver-based Redfund, is the first fully automated, business-to-business (B2B) international auction platform for wholesale cannabis and cannabis products. It also handles hemp and hemp products as well as genetics.

READ: Redfund Capital to take 5.6% stake in Mary’s Wellness

"Investing in a working cannabis auction platform in the sector is a game changer,” Redfund CEO Meris Kott said in a statement.

Cannamerx connects European buyers with Canadian licensed sellers and allows South American licensed producers to list their products globally with a click of a mouse.

More than 50 Canadian licensed cannabis companies have joined Ottawa-based Cannamerx, according to Redfund. Since June 2018, the auction platform has helped facilitate the trade of more than 25 tonnes of cannabis and more than C$22 million in bids received through its automated auction platform as well as its supply agreement auction process.

'Very excited'

“We are very excited to be working with Redfund,” Cannamerx CEO Dietwald Claus said. “Redfund’s resources and international network in the cannabis and hemp industry will accelerate our plans to position Cannamerx as the leading international marketplace for cannabis and hemp.”

Shares of Redfund climbed C$0.02 to C$0.23 in Tuesday’s Canadian trading. They traded at US$0.17 on the OTC Markets.

Earlier this month, Redfund announced plans to convert the first tranche of a convertible secured promissory note with cannabis tea client Mary’s Wellness Ltd into shares.

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Wed, 20 Mar 2019 08:23:00 -0400 https://www.proactiveinvestors.com/companies/news/216846/redfund-announces-strategic-alliance-with-hemp-auction-platform-cannamerx-216846.html
<![CDATA[News - Redfund Capital to take 5.6% stake in Mary’s Wellness; shares pop ]]> https://www.proactiveinvestors.com/companies/news/216397/redfund-capital-to-take-56-stake-in--marys-wellness-shares-pop-216397.html Redfund Capital Corp (CSE:LOAN, OTC:PNNRF), the cannabis-focused financier, revealed plans to convert the first tranche of a convertible secured promissory note with cannabis tea client Mary’s Wellness Ltd into shares.

In October, 2018, Redfund and Mary’s signed a two-year term convertible secured promissory note for $1 million at an annual interest rate of 12.5%. Mary's was extended a first tranche of C$100,000.

Upon converting this first tranche, Redfund will own 5.55% of Mary’s Wellness Ltd. The balance of the note is therefore C$900,000.

Shares in Toronto jumped 14% to $0.245.

READ: Redfund Capital finances Mary’s Wellness - the pot infused tea beverage firm

Mary’s Wellness Ltd was founded by Virginia Vidal two years ago as a response to the birth of her triplets in 2007.

The group's current product line is 100% organic, focused on medicinal cannabis and has a total of 18 varieties of convenient on-the-go brews.

Mary’s is working on filing documentation to the Canadian government when regulations on new licensed classes of cannabis for edibles are written. Mary’s is also in discussion with various Canadian licensed cannabis producers to produce tea products.

Mary’s Canadian only revenue projections once Canadian licensing approval is granted to edibles, are estimated at  $5.5 million for the first year and a steady growth projection to $8.5 million the second year.

Global projections

Additionally, its global projections near $12 million of international sales year one including a CBD infused tea rollout strategy.

"Redfund believes Mary’s Wellness is primed to be one of the first infused tea companies to reach the global marketplace. Virginia Vidal is a charismatic brand ambassador and a wonderful advocate for the medical cannabis industry in Canada," said Meris Kott,  Redfund CEO on Wednesday.

"She is actively working to align MWL with a strong Canadian licensed producer with an extensive distribution network to facilitate a successful entrance into the Canadian licensed market," added Kott.

Contact Giles at giles@proactiveinvestors.com

Follow him on Twitter @Gile74

]]>
Wed, 13 Mar 2019 09:29:00 -0400 https://www.proactiveinvestors.com/companies/news/216397/redfund-capital-to-take-56-stake-in--marys-wellness-shares-pop-216397.html
<![CDATA[Media files - Redfund Capital brings on CBD water company, launches new drinks products division ]]> https://www.proactiveinvestors.com/companies/stocktube/12395/redfund-capital-brings-on-cbd-water-company-launches-new-drinks-products-division-12395.html Thu, 28 Feb 2019 12:53:00 -0500 https://www.proactiveinvestors.com/companies/stocktube/12395/redfund-capital-brings-on-cbd-water-company-launches-new-drinks-products-division-12395.html <![CDATA[News - Redfund Capital to fund CBD water company Cannaki Beverage ]]> https://www.proactiveinvestors.com/companies/news/215421/redfund-capital-to-fund-cbd-water-company-cannaki-beverage-215421.html Redfund Capital Corp, the cannabis-focused investment firm, (CSE:LOAN) (OTCMKTS:PNNRF) said Wednesday that it has agreed to fund Cannaki Beverage Inc, a nano cannabidiol (CBD)-infused water company.

Headquartered in Las Vegas, Cannaki produces a range of still and sparkling flavored waters. The Nevada company is also set to roll out a new line of hemp and guayusa beverages in April of 2018.

READ: Redfund Capital client Wildflower Brands makes a splash at Oscars, catching the eye of A-listers

“Partnering with a water company with a strong footprint is a tremendous opportunity for Redfund,” said Meris Kott, Redfund CEO in a statement. “Cannaki has still, sparkling, flavored, plus Pet water, and a global presence as well.”

READ: Redfund Capital launches new drinks products division, shares jump

Under the terms of the deal, Redfund has signed a convertible note term sheet with Cannaki for US$1 million at a rate of 14% interest with a term of two years. Redfund and Cannaki will be finalizing a promissory note and security document in the next week and will share details of the completed transaction at that time.

Based in Vancouver, Redfund provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

Contact Ellen Kelleher at ellen@proactiveinvestors.com 

]]>
Wed, 27 Feb 2019 07:53:00 -0500 https://www.proactiveinvestors.com/companies/news/215421/redfund-capital-to-fund-cbd-water-company-cannaki-beverage-215421.html
<![CDATA[News - Redfund Capital client Wildflower Brands makes a splash at Oscars, catching the eye of A-listers ]]> https://www.proactiveinvestors.com/companies/news/215228/redfund-capital-client-wildflower-brands-makes-a-splash-at-oscars-catching-the-eye-of-a-listers-215228.html Regardless of who won an Oscar on Sunday, no nominee, presenter or performer at the event walked away empty-handed.

Cannabis financier Redfund Capital Corp (CSE:LOAN) (OTC:PNNRF) said Monday that the CBD products of its client Wildflower Brands were hand-picked for the 2019 Four Seasons Hotel Hollywood swag bag.

Founded in Vancouver, Wildflower Brands Inc (CSE:SUN) (OTC:WLDFF ) was selected to provide gifts for the nominees, presenters and talent staying at the luxury Four Seasons Hotel in Los Angeles for the 2019 Oscars.

The swag bag included Wildflower’s all-natural CBD Cool Stick, which the company says is formulated with a blend of plant-based ingredients to help with relief of muscle, joint and back pain. It is soothing and moisturizing with coconut oil, hemp oil, shea butter, beeswax, vitamin E, arnica, full spectrum CBD oil, peppermint and other essential oils, according to the company.

READ: US private equity giant KKR weighing up bid for Walmart-owned Asda

“It is exciting to see Canadian companies such as popular Wildflower featured on the worldwide stage as CBD products become mainstream in the retail US marketplace,” said Redfund Capital Corp CEO Meris Kott.

Redfund Capital’s incubator program includes marketing initiatives plus exposure to its clients’ brands to help get them global exposure. The company partnered with Karen Lee, the founder of Kaleidoscope Health and Ripped Femme, who played a key role in getting the Wildflower products featured in a talent give-away products bag for the 2019 Oscars.

“I want to thank Karen for this marketing opportunity and look forward to her continued support with Redfund’s accelerator and incubator programs," said Kott. "Exposure for our clients’ branded products is key to their successes.”

This year, there's been a heavy emphasis on cannabis-laced goodies in swag bags, from CBD-infused face cream and bath salts to edibles and even a VIP membership to a "cannabis-friendly" private club in Los Angeles, reported CNBC.

Based in Vancouver, Redfund provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive 

]]>
Mon, 25 Feb 2019 07:52:00 -0500 https://www.proactiveinvestors.com/companies/news/215228/redfund-capital-client-wildflower-brands-makes-a-splash-at-oscars-catching-the-eye-of-a-listers-215228.html
<![CDATA[News - Redfund Capital expands deal with Wahupta Ventures to provide new financing ]]> https://www.proactiveinvestors.com/companies/news/215064/redfund-capital-expands-deal-with-wahupta-ventures-to-provide-new-financing-215064.html Redfund Capital Corp (CSE:LOAN) (OTCMKTS:PNNRF) said Thursday that it has expanded its advisory deal with Wahupta Ventures Inc. to include new financing.

Vancouver-based Redfund has agreed to invest up to $1 million in Wahupta to help build out its growing Canadian hemp operations.

READ: Redfund Capital taps industry veteran Warren D Cudney as new strategic advisor

Redfund Capital provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as health care and hemp and CBD-related products.

Wahupta, which is based in Canada, cultivates, processes and extracts hemp and cannibidiol (CBD) in collaboration with sovereign Indigenous communities throughout North America. The company is also partnered with Canadian hemp-food manufacturer Naturally Splendid Enterprises.

“We believe strongly in the team and their vision at Wahupta, and are eager as well to work with their partner Naturally Splendid in developing client and proprietary hemp products,” said Redfund CEO Meris Kott. “We look forward to helping assist Wahupta to the next level of their strategic plan with additional capital.”

Contact Paul Curcio at paul.curcio@proactiveinvestors.com

Follow him on Twitter @GoCurcioGo

]]>
Thu, 21 Feb 2019 09:43:00 -0500 https://www.proactiveinvestors.com/companies/news/215064/redfund-capital-expands-deal-with-wahupta-ventures-to-provide-new-financing-215064.html
<![CDATA[News - Redfund Capital launches new drinks products division, shares jump ]]> https://www.proactiveinvestors.com/companies/news/214813/redfund-capital-launches-new-drinks-products-division-shares-jump-214813.html Redfund Capital Corp (CSE:LOAN) (OTC:PNNRF), the cannabis-focused group, has announced the launch of a new drinks division.

It told investors in a statement Monday that its first beverage product group will consist of powdered flavored hemp seed and hemp-infused teas.

Markets responded favorably to the news, with Redfund shares jumping 10% at C$0.22 on Tuesday. 

READ: Redfund Capital taps industry veteran Warren D Cudney as new strategic advisor

Products will be manufactured with the latest technology where it has strategic alliances and where it will provide the raw materials, the Vancouver-based company said.

The move is part of its global expansion plan, said Redfund, and it is filling a key gap in the market for lifestyle-driven infused beverages as demand for upscale hospitality and health-wellness sectors start to boom.

"The launch of our own proprietary beverage product-line has been in the works for almost a year. This division will provide the go forward business development advisory services as an added benefit to portfolio clients," said Meris Kott, CEO at Redfund.

Cannabis-focused financier Redfund, aims to provide debt and equity funding for a target company’s development, or in technologies that are developed and validated by revenues.

Currently, its focus is on medical cannabis, hemp and CBD-related, healthcare-related target companies.

Contact Giles at giles@proactiveinvestors.com

NOTE: This article was updated to include a share price and a new quote from the Redfund CEO

]]>
Mon, 18 Feb 2019 07:32:00 -0500 https://www.proactiveinvestors.com/companies/news/214813/redfund-capital-launches-new-drinks-products-division-shares-jump-214813.html
<![CDATA[News - Redfund Capital taps industry veteran Warren D Cudney as new strategic advisor ]]> https://www.proactiveinvestors.com/companies/news/214730/redfund-capital-taps-industry-veteran-warren-d-cudney-as-new-strategic-advisor-214730.html Cannabis financier Redfund Capital Corp (CSE:LOAN) (OTC:PNNRF) is tapping Wahupta Ventures Inc CEO Warren D Cudney as a new member of its advisory team.

Redfund also provided a first-quarter client financing rundown. It said it has extended funds to three cannabis companies.

READ: Redfund Capital sets off on new US-focused investment plan with hiring of strategic advisors

RxMM Health, which engages in hydroponic cultivation of medical cannabis in Australia, New Zealand, and the US, entered into a US$500,000 promissory note on October 1, 2018 and received its first tranche of C$220,740.

Similarly, Mary’s Wellness Ltd entered into a C$1,000,000 promissory note on October 15, 2018 and received the first tranche of C$100,000.

The third company, Seattle-based Winterlife Inc which makes gourmet cookies, tinctures, and capsules, entered into a US$1,000,000 promissory note on November 1, 2018 and received the first tranche of C$100,080.

“Redfund Capital is in the process of converting portfolio client loans into equity positions and building our global brand,” said Redfund CEO Meris Kott in a statement. “As an incubator, it is our role to help our clients increase their current valuations and grow organically to the next cycle in their lifespan.”

The Redfund CEO touted the “breakout” potential of Wahupta Ventures, which is focused on the cultivation, production, processing, and extraction of hemp and cannabidiol (CBD). Wahupta is headquartered in Canada and the US, with offices in Winnipeg, Burnaby in British Columbia, Orange County in California and Las Vegas.

“We believe Wahupta may be the next breakout leader in the hemp sector, and with their vertical operations and farm to field to consumer vision we are very proud to have them as a client in our portfolio and welcome Warren to our advisory team,” said Kott.

Based in Vancouver, Redfund provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive 

]]>
Fri, 15 Feb 2019 08:30:00 -0500 https://www.proactiveinvestors.com/companies/news/214730/redfund-capital-taps-industry-veteran-warren-d-cudney-as-new-strategic-advisor-214730.html
<![CDATA[Media files - Redfund Capital to expand US presence; updates on portfolio companies ]]> https://www.proactiveinvestors.com/companies/stocktube/12138/redfund-capital-to-expand-us-presence-updates-on-portfolio-companies-12138.html Thu, 07 Feb 2019 11:47:00 -0500 https://www.proactiveinvestors.com/companies/stocktube/12138/redfund-capital-to-expand-us-presence-updates-on-portfolio-companies-12138.html <![CDATA[News - Redfund Capital sets off on new US-focused investment plan with hiring of strategic advisors ]]> https://www.proactiveinvestors.com/companies/news/214201/redfund-capital-sets-off-on-new-us-focused-investment-plan-with-hiring-of-strategic-advisors-214201.html Cannabis financier Redfund Capital Corp (CSE:LOAN) said Thursday that it has recruited Wingspan Advisors and leading marketing expert Jerry Hug as it kicks off a new US-focused investment plan.

Hug will be Redfund’s first advisor to its newly-formed US advisory team and will work on positioning the cannabis investment company in the US market.

READ: Redfund private placements of C$1.7 million and C$1.4 million among key 2018 milestones

The Redfund team intends to focus on the CBD and hemp sector as it looks to target new investment opportunities in the US.

Hug’s first project will be to help to set up a working relationship with US partners for Redfund’s current portfolio companies.

READ: Redfund Capital arranges strategic alliance for two portfolio clients

“Redfund Capital is converting our strongest portfolio client loans into equity company positions this month,” said Redfund CEO Meris Kott in a statement. “As we build our American footprint, the Company has also begun our application to the OTCQB. We are excited to welcome Jerry to our team and his input and experience will be an invaluable asset to our growth.”

Hug is currently director of global operations for Cloud Commerce, a data-driven marketing company, in the US. Previously, he was also CEO of SITO Mobile, a mobile advertising company where he was instrumental in winning an uplisting to the NASDAQ market.

Based in Vancouver, Redfund provides debt and equity funding in the mid-to-late stages of a target cannabis company’s development. Its focus is on companies specializing in medical cannabis as well as healthcare and hemp and CBD-related products.

RedFund shares held steady at C$0.26 in Thursday’s morning trading.

Contact Ellen Kelleher at ellen@proactiveinvestors.com

 

]]>
Thu, 07 Feb 2019 10:07:00 -0500 https://www.proactiveinvestors.com/companies/news/214201/redfund-capital-sets-off-on-new-us-focused-investment-plan-with-hiring-of-strategic-advisors-214201.html
<![CDATA[News - Redfund private placements of C$1.7 million and C$1.4 million among key 2018 milestones ]]> https://www.proactiveinvestors.com/companies/news/213525/redfund-private-placements-of-c17-million-and-c14-million-among-key-2018-milestones-213525.html Redfund Capital Corp (CSE:LOAN) said in a securities filing that private placements of C$1.7 million and C$1.4 million were among key milestones in 2018.

The Vancouver-based cannabis company financier said Monday that closed in October a private placement for C$1,717,500 by issuing 5.7 million units. Each unit consists of one common share and one warrant entitling the holder to one additional common share for C$0.55.

Redfund added that in August it closed a private placement and issued 7.7 million units at C$0.1875 for total proceeds of C$1,458,730. Each unit consists of one common share and one warrant entitling the holder to one additional common share for C$0.34 for a period of two years. The company has the right to accelerate the expiration date if the shares trade at C$0.47 for a period of 14 consecutive days.

READ: Redfund Capital arranges strategic alliance for two portfolio clients

Last month, the company said it had arranged a strategic alliance between two of its portfolio clients – privately owned Winterlife Inc and Mary's Wellness Ltd – to spur the launch of cannabis products internationally.

Redfund provides debt and equity funding for cannabis companies.

Shares slipped C$0.01 to C$0.25 in Monday’s Canadian trading.

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Tue, 29 Jan 2019 08:30:00 -0500 https://www.proactiveinvestors.com/companies/news/213525/redfund-private-placements-of-c17-million-and-c14-million-among-key-2018-milestones-213525.html
<![CDATA[News - Redfund Capital investor Palisade Global Investments says it’s no longer an insider ]]> https://www.proactiveinvestors.com/companies/news/211338/redfund-capital-investor-palisade-global-investments-says-its-no-longer-an-insider-211338.html An investor in Redfund Capital Corp. (CSE: LOAN), Palisade Global Investments Ltd, said it’s no longer an insider in the Vancouver-based cannabis finance company.

Belize-based Palisade said in a filing Friday that in October it had transferred Redfund warrants to an arm’s-length party. Palisade said that on August 2 it had acquired almost 4.3 million shares and almost 4.3 million warrants of Redfund Capital through a private placement financing.

READ: Redfund Capital portfolio client Biolog teams up with Cannabis Strategic Ventures

The shares represented 10.4% of issued and outstanding common shares while the shares and warrants represented 18.8% of the issued and outstanding common shares assuming the exercise of the warrants.

An insider is generally considered a party that owns more than 10% of a company’s stock.

Shares of Redfund (CSE:LOAN) fetched C$0.28 in Friday’s Canadian trading.

Earlier this month, Redfund said it had arranged a strategic alliance between two of its portfolio clients, privately owned Winterlife Inc and Mary's Wellness Ltd., to spur the launch of cannabis products internationally.

 

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Mon, 17 Dec 2018 09:11:00 -0500 https://www.proactiveinvestors.com/companies/news/211338/redfund-capital-investor-palisade-global-investments-says-its-no-longer-an-insider-211338.html
<![CDATA[News - Redfund Capital arranges strategic alliance for two portfolio clients ]]> https://www.proactiveinvestors.com/companies/news/211067/redfund-capital-arranges-strategic-alliance-for-two-portfolio-clients-211067.html Cannabis financier Redfund Capital Corp (CNSX:LOAN) said Wednesday that it has arranged a strategic alliance between two of its portfolio clients, privately-owned Winterlife Inc and Mary's Wellness Ltd., to spur the launch of cannabis products internationally.

Since the cannabis industry is in the middle of a major global branding battle, Redfund has orchestrated a strategic partnership between Winterlife Inc and Mary's Wellness to first launch Mary's Wellness, a well-known Canadian tea brand in the United States.

READ: Redfund Capital broadens footprint in Europe: launches medical cannabis accelerator and incubator subsidiary

Mary’s Wellness is based in Ontario, Canada and was founded by Virginia Vidal in 2016. She was inspired to start the line of infused hot beverages to help manage her pain after the birth of her triplets in 2007. Since then, Mary’s brand has become synonymous as a symbol of wellness through cannabis.

Seattle-based Winterlife has close to C$3 million in sales through 600 dispensaries and has just launched the WinterlifeCBD product line, which is free of tetrahydrocannabinol (THC). The cannabis edibles company produces a brand of vegan and gluten-free cookies.

"In business, cooperation is the key to growth. Mary's Wellness stands out as a complementary brand to Winterlife Cannabis and Winterlife CBD. We are excited to help Virginia launch her infused brew on-the-go tea products into Washington State and expand nationally. Our consumers will benefit from a wider selection of healthy natural products," said Winterlife co-founder and creative director Charity Cox.

"Mary's Wellness is an experience into traditional authenticity; our family is beyond happy to bring our portfolio of Cannabis Wellness Beverages to an expanded market with the assistance of Winterlife Inc. We can also look forward to continued growth into a global brand with Redfund," Mary’s Wellness chief operations officer Ricardo Batho.

Redfund provides debt and equity funding in the mid-to-late stages of a target company's development or in technologies that are developed and validated by revenues.

“Helping companies organically grow and build their valuation by increasing their revenues has always been at the core of our business model,” Redfund Capital Corp CEO Meris Kott said in a statement.  

“We look forward to Winterlife's national expansion and Mary's Wellness launch abroad and both companies looking to the public markets for their own listings in 2019," added Kott.

 

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive 

]]>
Wed, 12 Dec 2018 09:08:00 -0500 https://www.proactiveinvestors.com/companies/news/211067/redfund-capital-arranges-strategic-alliance-for-two-portfolio-clients-211067.html
<![CDATA[News - Redfund client Mary’s Wellness CEO Virginia Vidal to speak at O’Cannabiz conference ]]> https://www.proactiveinvestors.com/companies/news/210686/redfund-client-marys-wellness-ceo-virginia-vidal-to-speak-at-ocannabiz-conference-210686.html Redfund Capital Corp (CSE LOAN) (OTCMKTS:PNNRF) said Thursday that Virginia Vidal, CEO of client company Mary’s Wellness Ltd, will speak on edibles, infused foods and beverages as a panelist on the  O’Cannabiz cannabis conference and exposition next week.

The conference, scheduled for December 10-11, will have former talk show host Montel Williams as keynote speaker. Diagnosed with multiple sclerosis in 1999, he has been an advocate for the use of medical marijuana. 

READ: Redfund Capital portfolio client Biolog teams up with Cannabis Strategic Ventures

Williams is a former US Marine who has worked to pass cannabis legislation and has pushed for military veterans to have access to medical cannabis without the threat of losing benefits, according to Redfund.

“O’Cannabiz is more about medical cannabis than any other show and it is what differentiates Redfund from other funders as we are focused on financing medical cannabis,” Meris Kott, CEO of Redfund, said in a press release.

Amanda De Freitas, Redfund director, and Kott will discuss the ability to track cannabis supply chains, sales and transactions digitally.

Shares of Redfund climbed C$0.01 to C$0.30 in Wednesday’s Canadian trading


Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Thu, 06 Dec 2018 08:23:00 -0500 https://www.proactiveinvestors.com/companies/news/210686/redfund-client-marys-wellness-ceo-virginia-vidal-to-speak-at-ocannabiz-conference-210686.html
<![CDATA[News - Redfund Capital portfolio client Biolog teams up with Cannabis Strategic Ventures ]]> https://www.proactiveinvestors.com/companies/news/210136/redfund-capital-portfolio-client-biolog-teams-up-with-cannabis-strategic-ventures-210136.html Redfund Capital Corp (CNSX:LOAN) said Wednesday that a portfolio client, Biolog Inc, has formed a partnership with Cannabis Strategic Ventures Inc (OTCMKTS:NUGS) to develop water-soluble cannabis.

The Vancouver-based medical cannabis financier said in a press release that the product would be used as ingredients for cannabis- and phytocannabinoid-rich foods, beverages and consumer products. Under the agreement, Hayward, California-based Biolog and Los Angeles-based Cannabis Strategic Ventures will team up on marketing.

READ: Redfund Capital says cannabis legalization in 3 more US states a milestone

Various existing techniques to make cannabinoids water-soluble have drawbacks, according to Redfund. The joint development effort between Biolog and Cannabis Strategic Ventures will seek to push past current limitations to develop a new set of functional cannabinoid ingredients that can be easily added to foods, beverages, cosmetics and other consumer products, Redfund said.

“Water-soluble cannabis technologies open new avenues for the development of cannabinoid-based products," Simon Yu, CEO of Cannabis Strategic Ventures, said in a statement.

Redfund Capital CEO Meris Kott added that “working alongside Cannabis Strategic Ventures and assisting them to realize their mandate building their products brands using Biolog technology shows collaboration of incubators in the space.”

Shares of Redfund closed at C$0.44 in Tuesday’s Canadian trading. Shares of Cannabis Strategic Ventures slipped US$0.34 to US$1.89 on the OTC market.


Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Wed, 28 Nov 2018 08:22:00 -0500 https://www.proactiveinvestors.com/companies/news/210136/redfund-capital-portfolio-client-biolog-teams-up-with-cannabis-strategic-ventures-210136.html
<![CDATA[News - Redfund Capital ready to forge strong cannabis banking ties with Israel ]]> https://www.proactiveinvestors.com/companies/news/209380/Redfund-Capital-ready-to-forge-strong-cannabis-banking-ties-with-Israel-209380.html Redfund Capital Corp  (CSE:LOAN, OTCMKTS:PNNRF) said Friday that it’s ready to forge a strong banking relationship with Israel after a parliamentary committee advanced legislation that would allow exports of medical cannabis from the Mideast country.

The bill will go to the Knesset for first reading after approval by the Internal Affairs and Environment Committee. Its chairman, Yoav Kisch, and Minister of Public Security Gilad Erdan have agreed to promote the legislation.

READ: Redfund Capital says cannabis legalization in 3 more US states a milestone

Since the 1990s, medical cannabis in Israel has been prescribed to patients for pain-related to Parkinson's, multiple sclerosis and other illnesses, according to Redfund.

“We are looking to Israel as our next country to forge strong relationships for our banking initiatives,” Redfund CEO Meris Kott said in a statement. “Israel has always led with a strong generic drug footprint.”

Redfund has identified Israeli portfolio companies including a technology firm, a medical products and cannabidiol (CBD) outfit and a grower with operations abroad and research and development facilities in Israel.

Israeli farmers who have applied for cannabis licenses in anticipation of legalized medical exports are becoming frustrated by gridlock, according to Redfund.

Shares of Redfund slipped C$0.01 to C$0.40 at the close Thursday on the Canadian Securities Exchange.

 

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Fri, 16 Nov 2018 08:38:00 -0500 https://www.proactiveinvestors.com/companies/news/209380/Redfund-Capital-ready-to-forge-strong-cannabis-banking-ties-with-Israel-209380.html
<![CDATA[News - Redfund Capital sets goal of helping CBD-focused Winterlife go public in 2Q ]]> https://www.proactiveinvestors.com/companies/news/209189/redfund-capital-sets-goal-of-helping-cbd-focused-winterlife-go-public-in-2q-209189.html Cannabis financier Redfund Capital (CSE:LOAN) said Wednesday it is working to help cannabidiol company Winterlife Inc go public in the second quarter of 2019.

Seattle-based Winterlife has close to C$3 million in sales through 600 dispensaries and has just launched the WinterlifeCBD product line, which is free of tetrahydrocannabinol (THC). The cannabis edibles company produces a brand of vegan and gluten-free cookies.

READ: Redfund Capital Corp bolsters client list with edibles cannabis brand, Winterlife Cannabis

“With a goal of helping Winterlife become a public company in the second quarter of 2019, this superior brand will be as easily identifiable as any other national or globally recognized cookies and snacks company,” Vancouver-based Redfund CEO Meris Kott said in a statement.

Redfund and Winterlife signed on November 1 a two-year term convertible secured promissory note for C$1 million at an annual interest rate of 14%.

Shares of Redfund closed at $0.52 on Wednesday in Canadian Securities Exchange trading.

 

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com


 

]]>
Wed, 14 Nov 2018 08:18:00 -0500 https://www.proactiveinvestors.com/companies/news/209189/redfund-capital-sets-goal-of-helping-cbd-focused-winterlife-go-public-in-2q-209189.html
<![CDATA[News - Redfund Capital says cannabis tea client Mary’s Wellness looking for global growth ]]> https://www.proactiveinvestors.com/companies/news/209039/redfund-capital-says-cannabis-tea-client-marys-wellness-looking-for-global-growth-209039.html Redfund Capital Corp (CSE:LOAN, OTC:PNNRF) said Monday that cannabis tea client Mary’s Wellness Ltd is taking steps to become a global brand and aims to go public next year.

The Vancouver-based, cannabis-focused financier added that it’s in discussions to launch Mary’s line of cannabis-infused tea in the United Kingdom, Switzerland, Colombia and Portugal.

“Creating a worldwide brand like Starbucks is exactly what we are planning with Mary’s,” Redfund CEO Meris Kott said in a statement. “Our goal for the first quarter of 2019 is to finance and list Mary’s Wellness on a public exchange.”

READ: Redfund Capital says cannabis legalization in 3 more US states a milestone

Last month, Redfund and Mary’s signed a two-year term convertible secured promissory note for $1 million at an annual interest rate of 12.5%

Mary’s is working on filing documentation to the Canadian government when regulations on new licensed classes of cannabis for edibles are written. Mary’s is also in discussion with various Canadian licensed cannabis producers to produce tea products.

"We are excited for the opportunity to share our original Canadian infused tea blends and our family brand with the world's most renowned tea enthusiasts from Europe to South America," Mary’s Wellness Founder and CEO Virginia Vidal said.

In October, Canada made it legal for adults to purchase, cultivate and use small amounts of marijuana. Last week, in Tuesday’s midterm US elections, Michigan became the 10th state to approve recreational use of marijuana while Missouri and Utah voted in favor of allowing its medical use.

Redfund shares climbed $C0.03 to $C0.55 on the Canadian Securities Exchange on Monday. They slipped $0.01 to $0.38 in OTC trading.


Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Mon, 12 Nov 2018 12:30:00 -0500 https://www.proactiveinvestors.com/companies/news/209039/redfund-capital-says-cannabis-tea-client-marys-wellness-looking-for-global-growth-209039.html
<![CDATA[News - Redfund Capital says cannabis legalization in 3 more US states a milestone ]]> https://www.proactiveinvestors.com/companies/news/208938/redfund-capital-says-cannabis-legalization-in-3-more-us-states-a-milestone-208938.html Medical cannabis financier Redfund Capital Corp (CSE:LOAN) said Friday that legalization of marijuana in three additional US states is a milestone for the industry and its clients.

In Tuesday’s midterm US elections, Michigan became the 10th state to approve recreational use of marijuana while Missouri and Utah voted in favor of allowing its medical use. North Dakota rejected allowing recreational pot, and marijuana remains illegal at the federal level.

In morning trading in Canada, Redfund shares were up 6% to C$0.53, while its US-listed stock was flat at US$0.38 per share on the OTC Markets.

READ: Crop Infrastructure thanks 3 US states for legalizing marijuana

“The midterm elections are a positive sign to all of us that the United States will mainstream medical cannabis in the very near future,” CEO Meris Kott said in a statement. “We look forward to expanding into markets supporting these initiatives."

Vancouver-based Redfund’s clients include Biolog Inc, a Silicon Valley company that is advancing a technology to add cannabis to food and beverages, and RxMM Health Care, a company in Irvine, California, whose products including a treatment for Alzheimer’s.

Legalization of marijuana is also moving forward outside the United States.

READ: Redfund Capital aiming to have 20 companies in portfolio in 2019

As of November 1, doctors in the United Kingdom can prescribe medical cannabis when other treatments have failed. The decision comes after two boys with severe epilepsy were denied treatments.

Redfund shares nudged  up 2% in Torontro to stand at $0.51.

Contact Dennis Fitzgerald at dennis@proactiveinvestors.com

]]>
Fri, 09 Nov 2018 09:56:00 -0500 https://www.proactiveinvestors.com/companies/news/208938/redfund-capital-says-cannabis-legalization-in-3-more-us-states-a-milestone-208938.html
<![CDATA[News - Redfund Capital aiming to have 20 companies in portfolio in 2019 ]]> https://www.proactiveinvestors.com/companies/news/208862/redfund-capital-aiming-to-have-20-companies-in-portfolio-in-2019-208862.html Cannabis-focused merchant bank Redfund Capital Corp (CSE:LOAN) outlined its vision for next year, saying it wanted to have a portfolio of 20 companies with $75 million that it had injected via its loans.

The company has already extended funds for five signed promissory notes and has over 11 companies in the pipeline at various stages of due diligence, it noted in the update.

The return on investment on any new emerging market tends to be a year or more down the line, it noted, adding that cannabis globalization is already here and will only expand in the coming year.

"The hot IPO [initial public offering] scenario is actually still in its infancy for the medical cannabis industry as it mainstreams, and we are looking forward to our portfolio companies being leaders in the public markets," said Meris Kott, chief executive of Redfund.

Redfund's loan portfolio as at November 5 this year is as follows:

Biolog Inc. - a cannabis infusion technology company, based in Silicon Valley, California, that has developed a patented system to infuse food and beverages with cannabis. Biominerales Pharma Colombia -  a  trailblazer in Colombia medical cannabis that has the trifecta of licences in Colombia allowing the company to grow, process and export CBD oil beyond South America Mary's Wellness Ltd. - founded by Virginia Vidal, a cannabis beverage trailblazer and a global medical cannabis influencer with a current product line of 100-per-cent-organic items focused on medicinal cannabis. Winterlife Inc, which has close to $3-million in sales through 600 dispensaries and has just launched the WinterlifeCBD product line that is free of THC (tetrahydrocannabinol), is 100 per cent organic, vegan and gluten-free. RxMM Health Care -- a division of RxMM Health Capital involved in the manufacturing of CBD over-the-counter medications, and Alzheimers Defense, a proprietary, CBD-infused all-natural nutraceutical product.

Redfund Capital shares are up over 3% in Toronto to stand at $0.50.

]]>
Thu, 08 Nov 2018 09:57:00 -0500 https://www.proactiveinvestors.com/companies/news/208862/redfund-capital-aiming-to-have-20-companies-in-portfolio-in-2019-208862.html
<![CDATA[News - Redfund Capital broadens footprint in Europe: launches medical cannabis accelerator and incubator subsidiary ]]> https://www.proactiveinvestors.com/companies/news/208268/redfund-capital-broadens-footprint-in-europe-launches-medical-cannabis-accelerator-and-incubator-subsidiary-208268.html Redfund Capital Corp (CSE:LOAN) unveiled exciting news Wednesday as it announced it was entering the European medical cannabis market with the launch of its subsidiary, First Euro Cannabis and says it is aiming to raise more than C$5 million for projects. 

Markets responded, with shares of Redfund Capital up 3.9% at C$0.49 on Wednesday.

First Euro is the first medical cannabis incubator and accelerator in Europe, which finances medical cannabis, cannabidiol and hemp companies. 

First Euro Cannabis will focus on sourcing strong investments in the growing number of companies involved in the space.

Redfund says having a European team on the ground in Switzerland and London is key and will assist in helping the company provide debt financing. 

READ: Redfund Capital finances Mary’s Wellness - the pot infused tea beverage firm

"The new first if its kind going-global program of First Euro Cannabis will adapt to the needs and reality of these cannabis company scale-ups, designed to improve the chances for a successful first to market international branding launch for these companies across the pond to North America as well," the company said in a release.

"A bad financing decision or strategic partnership can be fatal to any company and a small bridge loan has always been the right route to go for any company to step up to the next phase in their growth cycle," said Redfund's chief executive officer Meris Kott.

"Redfund is hoping to raise over C$5,000,000 for First Euro Cannabis medical cannabis projects." 

Redfund provides debt and equity funding in the mid-to-late stages of a target company's development or in technologies that are developed and validated by revenues.

The focus of the merchant bank is currently on medical cannabis, hemp and CBD-related and healthcare-related target companies.

READ: Redfund Capital finances medical pot group with potentially revolutionary Alzheimer's product

The timing is ripe: tomorrow, on November 1, the UK will approve legislation allowing specialist doctors, such as neurologists and pediatricians in England, Wales, and Scotland to prescribe medicinal cannabis to their patients.

Redfund says stigma around medical cannabis remains an issue in the UK, even with the change in laws.

The company says it welcomes the fact that these new laws will help patients with epilepsy, multiple sclerosis and nausea from cancer treatment, if prescribed by their physicians. 

Shares of Redfund were up 3.9% at C$0.49 on Wednesday. 

]]>
Wed, 31 Oct 2018 13:14:00 -0400 https://www.proactiveinvestors.com/companies/news/208268/redfund-capital-broadens-footprint-in-europe-launches-medical-cannabis-accelerator-and-incubator-subsidiary-208268.html
<![CDATA[News - Redfund Capital to support women entrepreneurs in the medical cannabis market ]]> https://www.proactiveinvestors.com/companies/news/207208/redfund-capital-to-support-women-entrepreneurs-in-the-medical-cannabis-market-207208.html Redfund Capital Corp (CSE:LOAN; OTC:PNNRF) said Tuesday that the Canadian cannabis-focused merchant bank was committed to following a gender equality funding strategy and would finance women-led medical cannabis companies.

“The funding of medical cannabis, CBD and hemp related companies remains the core focus of Redfund Capital,” said Redfund Capital CEO Meris Kott.

The bank said it is currently reviewing multiple women-led projects and would announce a list of clients once promissory notes had been signed with the entrepreneurs.

BIG PICTURE: ‘Cannabis 2.0 is here’: Redfund Capital fires up to serve maturing cannabis market

Redfund Capital is a cannabis merchant bank that provides an alternative source of capital through a debt facility to bridge finance and helps revenue producing cannabis-related companies build their valuation, and grow their company without diluting their equity prematurely, while helping move them toward being publicly listed.

Redfund said one of its directors would moderate a panel at the Institutional Capital & Cannabis Conference (IC3) in New York on October 22.

Contact Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive 

 

]]>
Tue, 16 Oct 2018 10:39:00 -0400 https://www.proactiveinvestors.com/companies/news/207208/redfund-capital-to-support-women-entrepreneurs-in-the-medical-cannabis-market-207208.html
<![CDATA[News - Redfund Capital finances medical pot group with potentially revolutionary Alzheimer's product ]]> https://www.proactiveinvestors.com/companies/news/206698/redfund-capital-finances-medical-pot-group-with-potentially-revolutionary-alzheimer-s-product-206698.html Cannabis-focused merchant bank Redfund Capital Corp (CSE:LOAN) revealed it is to provide finance to a company, which has produced a potentially revolutionary product to help Alzheimer's sufferers.

RxMM Healthcare Inc is the subsidiary of RxMM Health Capital and consists of six subsidiary companies involved in the cultivation and manufacturing of pharmaceutical grade cannabis for over-the-counter medications and wellness products.

READ: Redfund Capital's Colombian client BMP receives first purchase order

It is planning to have more than 4 million square feet (sq ft) of pharma-grade cannabis under cultivation by mid-2022.

Its healthcare products to be marketed consist of Alzheimer’s Defense (AD) daily tablets, Alzheimer’s Defense PLUS+ CBD daily gel caps.

There is also the FDA approved NeuroNasal Strips and CBD PLUS+ anti-oxidant topical patches to support overall antioxidant and anti-inflammatory wellness for up to 72-hours.

"For anyone who has watched a relative’s or friends’ memory disappear before them it is heartbreaking," said Meris Kott, the chief executive at Redfund.

"If Alzheimer Defense helps prevent or slow down the process of memory loss it is a miracle. 

"Redfund is excited to finance the building this revolutionary brand by RxMM and looks forward to supporting RxMM’s other subsidiaries in the near future with additional funding," she said.

READ: Redfund Capital reckons portfolio firm Biolog Inc is "on the cusp" of greatness

Alzheimers Defense (AD) is a proprietary, CBD infused "all natural" nutraceutical product, whose claims are underpinned by two scientific research studies.

These were funded by the National Institutes of Health and conducted at the University of California, Irvine, Institute for Memory Impairments and Neurological Disorders (UCI MIND) and the University of Kentucky.

Currently, there is no other preventative Dementia/ Alzheimer product on the market with evidence to support product efficacy claims, noted Redfund.

Redfund and RxMM have inked a two-year convertible secured promissory note on October 5 this year for $500,000 at an annual interest rate of 14%, of which the first tranche is $200,000.

The note may be converted at Redfund’s discretion at any time during the term and Redfund has a right of first refusal to provide financing to RxMM upon the same business terms as are being offered to RxMM by any other funders.

Contact Giles at giles@proactiveinvestors.com

]]>
Tue, 09 Oct 2018 10:09:00 -0400 https://www.proactiveinvestors.com/companies/news/206698/redfund-capital-finances-medical-pot-group-with-potentially-revolutionary-alzheimer-s-product-206698.html
<![CDATA[News - Redfund Capital reckons portfolio firm Biolog Inc is "on the cusp" of greatness ]]> https://www.proactiveinvestors.com/companies/news/205763/redfund-capital-reckons-portfolio-firm-biolog-inc-is-on-the-cusp-of-greatness-205763.html Redfund Capital Corp (CSE:LOAN) says investee firm Biolog Inc is on the "cusp of greatness" as it outlined the progress of the Silicon Valley and  LA-based cannabis infusion specialist.

In August, Redfund and Biolog signed a two-year term convertible secured promissory note for $800,000 with an annual interest rate of 14%.

Biolog's technology is protected by multiple patents, including a patent portfolio licensed from Lexaria.

This allows the dosing of almost any food or beverage with either cannabidiol (CBD), tetrahydrocannabinol (THC) or any combination of these or other cannabinoids.

"Our licence from Lexaria is what separates Biolog products from all others," said Biolog's chief executive Bruce Bauer.

"By incorporating the DehydraTECH drug delivery platform into our products, the bitterness and the earthy taste of cannabis oil are masked, and this technology ensures quick and effective transportation into the bloodstream without degradation in the stomach or liver."

Bauer noted that the cannabidiol (CBD) market was projected to reach $2.1 billion by 2020

Redfund chief executive Meris Kott added: "New delivery systems with patented technology have become extremely relevant in the cannabis medical arena.

"These cutting-edge discoveries will continue to make CBD and medical cannabis mainstream drugs in the very near futures. Biolog is a company on the cusp of greatness and Redfund is pleased they are an early-stage portfolio company."

Biolog, noted Redfund, is progressing rapidly in its research, intellectual property (IP) development and product expansion on its planned menu of product lines.

These lines are Cannastix, CannaTab and CannaPro protein powder.

]]>
Wed, 26 Sep 2018 08:34:00 -0400 https://www.proactiveinvestors.com/companies/news/205763/redfund-capital-reckons-portfolio-firm-biolog-inc-is-on-the-cusp-of-greatness-205763.html
<![CDATA[News - Redfund Capital looking forward to helping Biominerales become the leading medical cannabis company in South America ]]> https://www.proactiveinvestors.com/companies/news/205569/redfund-capital-looking-forward-to-helping-biominerales-become-the-leading-medical-cannabis-company-in-south-america-205569.html Redfund Capital Corp (CSE:LOAN) updated on Biominerales Pharma Colombia (BMP Colombia) in which it completed its first investment of $3mln last month,  revealing it was granted last week its medicinal cannabis licensure for the national Colombian market.

"Biomerales Pharma has become the #1 trailblazer in Colombia medical cannabis, said Meris Kott, CEO at Redfund.

READ: Redfund Capital bolsters board with appointment of cannabis-trailblazer

"With only a few weeks remaining before their expected approval to start government certification for 25 different cannabis medicinal genetics, they have possibly outperformed every cannabis company in Colombia with their low-cost budget, experienced and well known Colombian management team and comprehensive medical platform.

"Redfund will continue to support BMP and looks forward to helping them become the #1 medical cannabis company in South America."

BMP Colombia has the trifecta of licenses in Colombia allowing the company to grow, process and export CBD oil beyond South America to the global marketplace.

In Corinto, the base cannabis farm features both greenhouse and outside growing operations totalling almost 2 million sq ft of outdoor and 15,000 sq ft of greenhouse, producing high volumes of organic medicinal cannabis.

In Tulua, BMP has another farm for growing industrial hemp for CBD.

The first phase in Tulua is projected to yield between 1.2 and 1.4 million pounds of biomass per year.

In Mondomo, BMP is completing a lab where the chief agronomist will execute a process of DNA testing and growing in-vitro to create a super strain of seeds and plants with the highest quality plants free of disease.

BMP is planning to open a series of mobile labs in addition to medical clinics to act as treatment and dispensary distribution centres.

Redfund and BMP signed a two-year term convertible secured promissory note on August 23 for $3M at an annual interest rate of 14%.

]]>
Mon, 24 Sep 2018 13:03:00 -0400 https://www.proactiveinvestors.com/companies/news/205569/redfund-capital-looking-forward-to-helping-biominerales-become-the-leading-medical-cannabis-company-in-south-america-205569.html
<![CDATA[News - Redfund Capital is new Canadian resident agent for US cannabis fertilizer company Plant Life ]]> https://www.proactiveinvestors.com/companies/news/205365/redfund-capital-is-new-canadian-resident-agent-for-us-cannabis-fertilizer-company-plant-life-205365.html Redfund Capital Corp (CSE:LOAN) announced Thursday that it is the new Canadian resident agent for the US cannabis fertilizer company Plant Life, which is looking to widen its reach into Canada.

Headquartered in Delray Beach, Florida, Plant Life already has an extensive business supplying fertilizer to cannabis growers in California and is poised to enter the Canadian market by establishing strategic partnerships with Canadian cannabis companies.

“Revenue producing Plant Life will continue to be a leader in cannabis fertilizers. We are excited to assist David Ellerstein footprint Plant Life into the Canadian market and build his global brand,” said Redfund CEO Meris Kott in a statement.

Shares of Redfund rose 50% to C$0.50 on heavy volume in midday trading in Canada.

Read: Redfund Capital completes US$3mln investment into Colombian cannabis group Biominerales

In the fertilizer business since the 1920s, Plant Life focuses on offering a superior line of fertilizers to cannabis companies. It manufactures liquid and dry water-soluble fertilizers designed to improve a plant’s growth cycle, maximize growers' yields and increase potency.

A Canadian merchant bank, Redfund looks to provide debt and equity funding in the mid-to-late stages of a target company’s development or in technologies that are validated by revenues. Redfund’s focus is currently on medical cannabis, hemp and CBD-related as well as healthcare-related target companies.

]]>
Thu, 20 Sep 2018 12:16:00 -0400 https://www.proactiveinvestors.com/companies/news/205365/redfund-capital-is-new-canadian-resident-agent-for-us-cannabis-fertilizer-company-plant-life-205365.html
<![CDATA[News - Redfund Capital completes US$3mln investment into Colombian cannabis group Biominerales ]]> https://www.proactiveinvestors.com/companies/news/203903/redfund-capital-completes-us3mln-investment-into-colombian-cannabis-group-biominerales-203903.html Redfund Capital Corp (CSE:LOAN) has completed its first investment - of US$3mln - into advanced Colombian cannabis group Biominerales Pharma Corp (BMP Colombia).

The group, first established in 2014, was one of the first Colombian companies authorised to legally market medical cannabis in Colombia, throughout South America and worldwide. The BMP team is located in Bogota and currently partners with 180 cultivators and works closely with chemical engineers, agronomists and top local and international doctors.

"As we continue to build one of the only Colombian vertically integrated supply chain and processing services in the Medicinal Cannabis and CBD industry, we are very excited to partner with Redfund," said Adriana Rios, chief executive at Biominerales Pharma.

"Their long-term support in helping us execute our overall strategy will accelerate our mission to develop best in class products and services and deliver on our social strategy to create jobs and assist local Colombian farmers.

"Having the financial backing of Redfund will bring further validation to our global model.

Meris Kott, chief executive at Redfund, added: "We have been working with Adriana and her team for many months and today marks a major success for both our companies. Felicidades!

Leader in Colombia

"Biominerales is a leader today in Colombia and will be one of the first to harvest a crop and place Colombia on the global Medicinal Cannabis and CBD stage. I am very proud to be partnering with one of the few Women in Cannabis in Colombia. Redfund will continue to finance BMP and help the company realize their complete business plan."

Last week, Redfund and BMP signed a two-year convertible secured promissory note for US$3mln, at an annual interest rate of 14%, of which the first tranche of US$200,000 has already been tendered.

The note can be converted at Redfund's discretion at any time during the term and the company also has a right of first refusal to provide financing to BMP upon the same business terms as are being offered to BMP by any other funders.

]]>
Thu, 30 Aug 2018 09:49:00 -0400 https://www.proactiveinvestors.com/companies/news/203903/redfund-capital-completes-us3mln-investment-into-colombian-cannabis-group-biominerales-203903.html
<![CDATA[News - Redfund Capital completes first investment with cannabis edibles infusions brand, Biolog ]]> https://www.proactiveinvestors.com/companies/news/203728/redfund-capital-completes-first-investment-with-cannabis-edibles-infusions-brand-biolog-203728.html Bright news for Redfund Capital Corp (CSE:LOAN) today after it announced Monday it has completed its first investment in Biolog Inc., a cannabis infusion technology company, based in Silicon Valley and Los Angeles, California.

Biolog has developed a patented system to infuse food and beverages with cannabis, which provides enhanced bioavailability — the amount of a substance that becomes available — and reduced onset times.

Redfund is a medical cannabis merchant bank that provides an alternative source of capital through loans to bridge finance and help medical cannabis-focused companies build valuation, and grow their businesses without diluting equity prematurely.

WATCH: Redfund Capital looks to help companies build their valuation and get to the next level

"Our analysis in selecting a financing partner extended well beyond simple access to capital. We rated industry expertise and the ability to assist us in developing strategic partnerships as our two main criteria. Redfund Capital was the clear choice for Biolog for these reasons. All of us at Biolog are very pleased to have Redfund as our partner in growth," said Bruce Bauer, CEO of Biolog.

The Biolog products are powered by Lexaria Bioscience Corp's (CSE:LXX) DehydraTECHTM technology, under a license agreement announced earlier this year.

The Biolog technology is protected by multiple patents and trade secrets, including a patent portfolio licensed from Lexaria, enabling consumers and processors to precisely dose almost any food or beverage with either cannabidiol (CBD), tetrahydrocannabinol (THC) or any combination of these or other cannabinoids. The company said CBD edibles manufactured with Biolog's technology could offer improvements in bioavailability of up to 500%, while also reducing onset times for psychoactive effects from tetrahydrocannabinol (THC) to as fast as 15 to 20 minutes.

READ: Women in weed: meet four women helping to shape Canada’s cannabis industry

"We are investing based on the exceptionally strong intellectual property portfolio owned by the company. As the medical cannabis and CBD business sectors mature, we believe differentiating factors and barriers to entry, such as the trade secrets and patents will become ever more important. Biolog brings to the market an already exceptional IP position, which we believe will be further strengthened over the coming year," Redfund chief executive officer, Meris Kott.

The Investment

Redfund and Biolog signed a 2-year term convertible secured promissory note on August 21, 2018 of US$800,000 at an annual interest rate of 14%, of which the first tranche of $200,000 has already been tendered to Biolog. The note may be converted at Redfund's discretion at any time during the term and the company has a right of first refusal to provide financing to Biolog upon the same business terms as are being offered to Biolog by any other funders.

Biolog afforded Redfund stock warrants of its common stock equivalent to twenty percent (20%) of the amount of the note based upon their current valuation as of the effective date which is stipulated to be US$10,000,000.00.

Additional rounds of funding from the company could further enhance Biolog's product portfolio, product line expansion and distribution.

]]>
Tue, 28 Aug 2018 13:05:00 -0400 https://www.proactiveinvestors.com/companies/news/203728/redfund-capital-completes-first-investment-with-cannabis-edibles-infusions-brand-biolog-203728.html
<![CDATA[News - Redfund Capital launches medical cannabis merchant bank; lists on Canadian Stock Exchange ]]> https://www.proactiveinvestors.com/companies/news/202881/redfund-capital-launches-medical-cannabis-merchant-bank-lists-on-canadian-stock-exchange-202881.html Bright news for Redfund Capital (CSE:LOAN) on Tuesday, after it announced its launch as one of the first medical cannabis merchant banks. The company is now listed on the Canadian Stock Exchange.

Redfund is one of the first medical cannabis merchant banks, with an aim to become a global top-tier medical cannabis incubator and accelerator providing debt and equity funding instruments to companies, which require project-specific financing. 

“The first focus of our merchant bank will be the financing of medical cannabis, CBD and hemp companies. Our initial portfolio companies will be announced in the next week, and we believe their strong business fundamentals and upside potential will bring immediate value to our shareholders,” said Meris Kott, CEO, Redfund Capital Corp.

WATCH: Redfund Capital looks to help companies build their valuation and get to the next level

Redfund’s merchant bank will provide an alternative source of capital through loans to bridge finance and help medical cannabis-focused companies build valuation, and grow their business without diluting equity prematurely.

The merchant bank is positioned to nurture its portfolio companies towards organic growth, public listings, and merger and acquisition strategies, through its incubator model.

]]>
Tue, 14 Aug 2018 11:23:00 -0400 https://www.proactiveinvestors.com/companies/news/202881/redfund-capital-launches-medical-cannabis-merchant-bank-lists-on-canadian-stock-exchange-202881.html
<![CDATA[News - Parana Copper closes C$2mln financing round, finalizes change of business to merchant bank, focusing on medical cannabis and hemp ]]> https://www.proactiveinvestors.com/companies/news/202138/parana-copper-closes-c2mln-financing-round-finalizes-change-of-business-to-merchant-bank-focusing-on-medical-cannabis-and-hemp-202138.html Parana Copper Corp. (CSE:COPR) hit a high bar this week as it announced it has completed its first tranche of a C$5mln non-brokered private placement, as well as completing its previously announced change of business to become a merchant bank, focusing on the medical cannabis, hemp and cannabidiol sector in Canada and the US. 

The company issued 6.7mln units at C$0.30 for total proceeds of C$2,008,730. Funds will be used for general corporate purposes. 

Each unit consists of one common share and one warrant, which entitles the holder to subscribe for one additional common share at C$0.55 for two years from closing, subject to the company having the right to accelerate the expiry date if the shares trade at C$0.75 for a period of 14 consecutive days, including days where no shares trade. 

READ: Redfund Capital Corp grows client list with cannabis edibles infusions brand, Biolog Inc

The company also announced it has issued 6.4mln common shares to the shareholders of Ultra invest Canada Inc. to acquire all of the currently issued and outstanding shares of Ultra, a non-arms-length private company controlled by the company's chief executive officer, Meris Kott, at a deemed price of C$0.15 per share.

Ultra has developed a base of potential banking customers. The company has agreed to issue another 1.5mln shares upon the exercise of outstanding Ultra options.

Company will change name to Redfund Capital

Subsequent to this, the company will effect a 1.6 for 1 stock split in conjunction with a name change to Redfund Capital Corp.

Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company's development, or in technologies that are developed and validated but may be in the early stage of commercialization.

After the stock split, there will be a total of 41.2mln shares outstanding.

The company said shares will start trading as Redfund, with the trading symbol LOAN, when it is advised.

Redfund is not bound to commit to any particular sector, thereby allowing for diversification; however, the present focus is generally on medical cannabis, hemp and CBD-related, healthcare-related target companies.

]]>
Thu, 02 Aug 2018 11:41:00 -0400 https://www.proactiveinvestors.com/companies/news/202138/parana-copper-closes-c2mln-financing-round-finalizes-change-of-business-to-merchant-bank-focusing-on-medical-cannabis-and-hemp-202138.html
<![CDATA[News - Redfund Capital Corp grows client list with cannabis edibles infusions brand, Biolog Inc ]]> https://www.proactiveinvestors.com/companies/news/199424/redfund-capital-corp-grows-client-list-with-cannabis-edibles-infusions-brand-biolog-inc-199424.html Redfund Capital Corp (CSE:COPR, OTC:PNNRF, Frankfurt:O3X4) announced today that it is adding a new client to its budding client list: Biolog Inc. 

Biolog has developed a patented system to infuse food and beverages with cannabis, which provides enhanced bioavailability — the amount of a substance that becomes available — and reduced onset times.

“Redfund Capital is specifically focused on funding cannabis-related companies that have strong growth potential and that is exactly what we see in Biolog,” said chief executive officer Meris Kott.

“Biolog’s products were specifically designed to solve the inconsistencies within the edible cannabis market and we are pleased to welcome them to the Redfund portfolio of companies.”

READ: ‘Cannabis 2.0 is here’: Redfund Capital fires up to serve maturing cannabis market

The Biolog products are powered by Lexaria Bioscience Corp's (CSE:LXX) DehydraTECHTM technology, under a license agreement announced earlier this year.

“The financing from Redfund will allow us to accelerate our product schedule. The patented process we deploy allows us to produce products that normal consumers or professional processors can utilize to turn virtually any food into a cannabis edible that is accurately dosed with highly bioavailable cannabinoids," said Bruce Bauer, chief executive officer of Biolog. 

"While we will enter the marketplace with a strong patent portfolio, our internally developed testing regime, which is based on some of the most advanced laboratory equipment in the market, will ensure that consumers and processors can use our products with confidence.”

Technology protected by patents

The Biolog technology is protected by multiple patents and trade secrets, including a patent portfolio licensed from Lexaria, enabling consumers and processors to precisely dose almost any food or beverage with either cannabidiol (CBD), tetrahydrocannabinol (THC) or any combination of these or other cannabinoids.

The company said CBD edibles manufactured with Biolog's technology could offer improvements in bioavailability of up to 500%, while also reducing onset times for psychoactive effects from tetrahydrocannabinol (THC) to as fast as 15 to 20 minutes. 

]]>
Fri, 22 Jun 2018 11:02:00 -0400 https://www.proactiveinvestors.com/companies/news/199424/redfund-capital-corp-grows-client-list-with-cannabis-edibles-infusions-brand-biolog-inc-199424.html
<![CDATA[News - A game-changing vote: Canadian senate votes ‘Yes’ to legalize recreational cannabis ]]> https://www.proactiveinvestors.com/companies/news/198501/a-game-changing-vote-canadian-senate-votes-yes-to-legalize-recreational-cannabis-198501.html Recreational cannabis advocates cheered Thursday night as the Canadian Senate voted to pass Bill C-45 — the landmark legislation to legalize recreational marijuana — by a vote of 56 to 30, with one abstention. 

It was high time, according to cannabis advocates. Canada is the second country in the world, behind Uruguay, to legalize recreational marijuana. Cannabis is partially or fully decriminalized in some countries, such as Switzerland and Spain, but Canada will be the first G7 nation to give commercial sale the go-ahead.

WATCH: Daily CryptoCann Report: Crypto art auction features Andy Warhol painting; Canada Senate may legalize recreational marijuana

“It’s a historic night for Canada in terms of progressive health policy and social policy,” said the bill's sponsor, Independent Senator Tony Dean.

Canada's Attorney General and Justice Minister, Jody Wilson-Raybould, echoed Sen. Dean's comments.  

"C-45 will create a strictly-regulated cannabis market, which will help keep it out of the hands of kids and take profits away from criminals," she Tweeted last night. "This is a milestone for progressive public policy."

Details still to hash out

There was fractious debate and a near-fatal vote along the pathway as bill C-45 moved through Parliament. And there are still a number of hurdles to pass through. 

The bill will now go on to the House of Commons for further review of the numerous 45 amendments (far more than most pieces of government legislation). 

The government must now decide which amendments to keep, modify and toss before sending the bill back to the Senate, where it will be voted on again.

Roll out could be delayed

Canada's Health Minister Ginette Petitpas Taylor said that once the bill is passed, provinces and territories will need two to three months to prepare — before cannabis is actually available in a retail setting. That is likely a best-case scenario.  

From a company perspective, many companies have welcomed the delay in the process, as it allows them a bit more time to get ready, particularly on the supply side, with many producers facing the challenge of having enough product to meet supply demands.

According to industry analysts, Canada’s cannabis industry could surpass C$22 billion in size over the coming years. 

US could further tap into the market

The change also has the potential to bring entrants to the market, as Canada's neighbours to the south look north, with an aim to tap into the industry. 

"I’m going to wear my American hat here. I think we’re going to see a huge influx of American companies that have already been working with Canadian companies on many of their products, move more into the market," said Meris Kott, CEO of Redfund Capital Corporation, a cannabis merchant bank that provides an alternative source of capital through a debt facility to bridge financing.

READ: Women in weed: meet four women helping to shape Canada’s cannabis industry

Kott has straddled both worlds, after originally getting into the cannabis industry in 2012 in Colorado, after Amendment 64 passed in the state. 

"I think the Americans are going to flood our market with new brands, technologies and licensing agreements, as well as other countries who have approved recreational cannabis already. It can only help create a successful global marketplace."

Nine states and Washington, DC, have legalized marijuana for recreational use for adults over the age of 21. 

Provinces to decide specifics

Individual provinces and territories in Canada will have significant power when it comes the specifics of recreational cannabis in Canada. The nationwide maximum for personal possession is set at 30 grams.

However, other specifics, such as implementation (government-operated or private industry), the eligible age of purchase (likely 18 or 19) and home cultivation rules were all be decided on by each specific province and territory. 

]]>
Thu, 07 Jun 2018 22:02:00 -0400 https://www.proactiveinvestors.com/companies/news/198501/a-game-changing-vote-canadian-senate-votes-yes-to-legalize-recreational-cannabis-198501.html
<![CDATA[News - Women in weed: meet four women helping to shape Canada’s cannabis industry ]]> https://www.proactiveinvestors.com/companies/news/197141/women-in-weed-meet-four-women-helping-to-shape-canadas-cannabis-industry-197141.html It’s a common story thread: women entrepreneurs blazing the way for cannabis, taking over the sector and inserting themselves into a market that is booming, complicated and fast-evolving.

Stop. Back it up. Wait a moment. This is not one of those stories.

It’s an easy – perhaps a bit lazy – trend to latch onto, one that weaves itself through the cannabis daily news cycle. “Women in weed: charting change for male-dominated cannabis culture,” blared a CBC headline earlier this year.

This is not to say that women aren’t powerhouses in the world of cannabis. They are: just like they are in each and every other sector, when put in positions of power to do so.

In order to survive in this sector, you have to have strong chops, a killer resolve and the tenacity to do whatever it takes. It’s that entrepreneurial spirit that is key. Being a woman just happens to be one part of the equation.

We spoke to four women who touch different corners of the cannabis industry. From financiers to investment bankers, from equipment manufacturing to recreational advocates, we chatted about their past, predictions and what might roll out ahead.

Interviewees:

Meris Kott – CEO at Redfund Capital Corporation. Redfund Capital is a cannabis merchant bank that provides an alternative source of capital through a debt facility to bridge finance and helps revenue producing cannabis related companies build their valuation, and grow their company without diluting their equity prematurely, while helping move them toward being publicly listed.

Yasmin Gordon – Senior investment advisor at Canaccord Genuity. Yasmin Gordon is co-founder of the Gordon Group, as part of Canaccord Genuity Wealth Management, and advises private clients, corporate entities and institutional investors.

Rosy Mondin – CEO at Quadron Cannatech Corporation (CSE:QCC). Quadron Cannatech (QCC) is a market and technology leader in end-to-end automated processing and extraction laboratory solutions for the international cannabis industry. QCC also provides a range of innovative value added services including custom ancillary products and cannabis accessories.

Ria Kitsch – VP Human Resources at Hiku Brands Company Ltd. (CSE:HIKU). Hiku is a cannabis house brand. Hiku's subsidiaries include Tokyo Smoke, DOJA, Van der Pop and Maïtri. 

Q: Tell me about how you got into this industry. What led you here?

MK: I come from an investment banking family, which funded emerging market growth companies. About 12 years ago, we started looking at the cannabis industry, and we didn’t touch it, figured it wasn’t ever going to happen. We got into the industry in 2012, after Amendment 64 passed in Colorado. We’re now launching the first debt facility merchant bank, Redfund Capital Corp., focused on funding cannabis related revenue producing companies.

YG: I am a Senior investment advisor with Canaccord Financial, specializing in non-traditional wealth management strategies with a niche in providing financing opportunities. I came into the cannabis sector, quite honestly, out of necessity – I could see there was a shift occurring as we got more clarity with regard to full out legalization in Canada. I saw the opportunity and decided to add exposure in a more significant way. It’s been an exciting ride.

RM: As CEO of Quadron Cannatech, and a leading advocate for the legalization of recreational cannabis in Canada, I’m thrilled to be at the forefront of this emerging industry. I’m the director for the Cannabis Trade Alliance of Canada (CTAC) and I also serve as a Special Advisor to the Canadian Association of Medical Cannabis Dispensaries (CAMCD). In my role with CTAC, I work with industry leaders, government legislators and educators to develop an inclusive, safe, and ethical cannabis industry. 

RK: I’m the vice president of HR at Hiku. Back in 2013, we saw an opportunity in getting into commercial cultivation, so we put in our application. We received our license to sell just this year. It’s been a long road but here we are. We merged with Tokyo Smoke in January. We then just recently merged with WeedMD in a pretty transformational transaction: combining a premium cannabis brand house and retail-focused operator. 

  Q: For some women, this might not be a sector that immediately comes to mind as a place to be. What advice would you give others who may not have considered this sector as a career path?

MK: Jump in! Because right now we're creating a whole new industry. 

That said, it has changed and it's become harder to break into the industry as a woman because it's becoming more mainstream. Women are generally the chief medical officer in their family and looking at cannabis products more closely. I also think because it's such a new industry people don't consider it as a career path and it is still a risky avenue for work to some women.

RM: We are building a new industry – we currently have just over 100 Licensed Producers across Canada. If you think about most industries, 104 commercial licensees nationally in the sector is not a true industry. 

We are slowly seeing more ancillary businesses coming into the fold: legal, accounting, marketing, government relations, business development, branding, packaging – and banking (slowly). In addition, the cannabis industry has been operating in an under-regulated space (as there was no other option). Now there’s a lot of opportunity during this transition into the regulated market. There's just so many areas that you can jump into as we build a whole industry so it's really up to your own imagination as to which way you want to go and how to get your feet wet.

  Q: What trends do you expect to see when recreational comes online later this year?

RM: I think the biggest shift will be the consumption of cannabis moving away from smoking traditional flower to products that are extract-based. Extracts form the basis for the majority of cannabis products outside of smoking: vapor-oils, capsules, tinctures, sublinguals, transdermal patches, edibles, topicals, suppositories, infused beverages. I have no doubt that we'll see different consumption methods and further product innovation. I think the sky's the limit.

MK: I’m going to wear my American hat here. I think we’re going to see a huge influx of American companies that have already been working with Canadian companies on many of their products, move more into the market. I think the Americans are going to flood our market with new brands, technologies and licensing agreements, as well as other countries who have approved recreational cannabis already. It can only help create a successful global marketplace.

YG: I see a shifting consciousness as to what legalization means for cannabis as many people will be forced to redefine what they know about the potential benefits of cannabis as a therapy option.  You know I find it very interesting with my clients. There’s a divide in my book of clients: there are those that are for investment and those that still believe it's a gateway drug. I believe perceptions will swing more positively as the public receives further education about the medicinal benefits of cannabis.

RK: It’s interesting when we talk about recreational. It’s a national movement that’s going to have so many ripples of effect. I’ve always believed that vaping and very clean, efficient methods are going to be preferred. However, we also believe that there’s a segment of the market, maybe 10% or so, that wants a curated strain and they want it in its entirety. It’s similar to going to a winery. You want to talk to a winemaker about how it’s grown, what it looks like, feels, tastes, etc.

 

Q: We’re seeing a lot more mergers and consolidations in the space. How do you differentiate yourself in a crowded market?

MK: In Canada, the companies are much smaller than other global players, although they are financed with plenty of capital. That said, you will see more consolidation between U.S. and Canadian companies. It is going to be about a recognized branded product first off.

RM: Like any industry, we’ll see consolidation, mergers, acquisitions and we’re going to see some businesses that will not make it – it’s the nature of any business. Look at the restaurant industry. It’s one thing to have a good idea: it’s another thing to actually execute it, using the restaurant example, understanding how to run a kitchen, avoid food-waste, or manage front-of-the-house. There will be consolidation, as licenses get scooped up through mergers. It’s just the normal course of a new and growing industry which continues to shift and evolve.

RK: There’s room for a range of different products in the competitive landscape. At the end of it, it’ll be key to have a really quality product, and maybe do fewer things but do them really well.

  Q: If there’s one lesson you’ve learned in the industry, that you think other women should know, what would it be?

YG: Being aware of trends as an investor in the industry. It’s shifting so quickly. It’s almost mind-blowing. Retail investors need to be aware of how quickly the industry is transforming and the trends that are coming out that make a buy and hold strategy not likely the most effective way to play this market given the volatility we are witnessing.

RM: This is a 21st-century industry and women can play a leadership role from day one. For example, as a business leader in a new industry, I don't think sitting back and just accepting the regulations at the government tables is acceptable. We’re getting out there and helping define the rules as the country moves forward. I think this kind of thing is really important. How do we encourage business investment and faith into the industry? I think having strong leadership, especially more women, can help.

MK: When I started in the industry it was two camps: medical marijuana and marijuana. Then we started talking about cannabis. It’s an industry now, a true marketplace. I think that from an entrepreneur's point of view it's become a cannabis investing haven. Just the fact that there are so many people involved, and that you can go on the CSE website and find a company directory in cannabis is exciting. There’s a mining sector, and now there’s a focused cannabis sector. Welcome to the industry. It’s not going anywhere.

RK: Don’t be afraid to be visionary.  The industry is moving so quickly. Look to something you think you understand or that you can replicate with confidence. Another country, another model, don’t be afraid to try unique things. Don’t feel that you have to do what everyone else is already doing. The future is ours to create.

All photos were taken by Matt Watson

 

]]>
Wed, 16 May 2018 17:17:00 -0400 https://www.proactiveinvestors.com/companies/news/197141/women-in-weed-meet-four-women-helping-to-shape-canadas-cannabis-industry-197141.html
<![CDATA[News - Redfund Capital Corp bolsters client list with edibles cannabis brand, Winterlife Cannabis ]]> https://www.proactiveinvestors.com/companies/news/197132/redfund-capital-corp-bolsters-client-list-with-edibles-cannabis-brand-winterlife-cannabis-197132.html Redfund Capital Corp. (CSE:COPR) today announced an exciting new client in its pot of gold client list: Winterlife Cannabis.

Redfund, previously under the name Parana Copper Corp, is a cannabis merchant bank that provides alternative funding through a debt facility to companies.

READ: ‘Cannabis 2.0 is here’: Redfund Capital fires up to serve maturing cannabis market

"Our investment will give Winterlife the ability to increase their SKUs and develop brand awareness for their product,” said chief executive officer, Meris Kott.

“The future of cannabis edibles whether drink mixers or cookies is in their brands just like other food items. Winterlife has already succeeded with its unique packaging and catchy animal themed product lines in developing their own consumer following,” she added. 

Not your grandma’s cookies

Winterlife is an internationally recognized cannabis edibles company based in Seattle, and available at more than 400 dispensaries in Washington State.

Its current product line includes gourmet cookies (vegan and gluten free), flavoured cocktail spikers, tinctures and capsules and specialty flower products.

With one of its catchy taglines being, “Edibles don’t have to taste like grass,” the company offers a proprietary extraction and processing method, which allows it to produce high potency extracts. In short? You taste the edibles, not the pot.

Brand expansion ahead

Currently, the company is focused on expanding its brand and positioning itself as recognized, established and trusted brand in the cannabis industry.

“B2B and B2C is all about branding and we cannot wait to see Winterlife Cannabis on shelves in dispensaries in every country that embraces recreational cannabis adult usage," said Kott.

]]>
Wed, 16 May 2018 12:12:00 -0400 https://www.proactiveinvestors.com/companies/news/197132/redfund-capital-corp-bolsters-client-list-with-edibles-cannabis-brand-winterlife-cannabis-197132.html
<![CDATA[News - Redfund announces new client: beverage dosing CBD Zone ]]> https://www.proactiveinvestors.com/companies/news/196795/redfund-announces-new-client-beverage-dosing-cbd-zone-196795.html News from Redfund Capital Corporation (CSE:COPR, OTC:PNNRF, Frankfurt:O3X4) (the “Company”) today as it annouced a new client, CBD ZONE LLC (“CBD”) and its beverage dosing technology.

CBD Zone LLC, delivers technology for creating enhanced CBD and THC infused beverages.

What does that mean? It uses the patented PowerCap®, an approach, which gives CBD Zone a unique position in the cannabis market providing new formulations to grow the business exponentially. 

READ: ‘Cannabis 2.0 is here’: Redfund Capital fires up to serve maturing cannabis market

PowerCap, stores measured CBD and THC within the cap creating controlled and stable dosing amounts of actives. It works similarly to infuser bottles and releases the beverage by releasing the flavored CBD mix with a push down of the cap.

“The simplicity of the product, the natural flavor, sweetener, color platform, the extended shelf life, and the ability to have measured dosages make it convenient for all ages to use," said chief executive officer, Meris Kott. "We are also extremely excited to help CBD Zone launch their products into the Canadian cannabis market."

Redfund has been booming as late with its investments that will be deployed to companies that have demonstrated success in the cannabis industry.

The merchant bank, which will focus on the funding of companies, provides debt and equity funding instruments to cannabis companies that require project-specific funding. It will also provide services to cannabis-related companies to help them move towards being publicly listed.

]]>
Fri, 11 May 2018 00:36:00 -0400 https://www.proactiveinvestors.com/companies/news/196795/redfund-announces-new-client-beverage-dosing-cbd-zone-196795.html
<![CDATA[News - Buds, Batteries and Blockchain: Redfund to showcase at Toronto investor summit ]]> https://www.proactiveinvestors.com/companies/news/195879/buds-batteries-and-blockchain-redfund-to-showcase-at-toronto-investor-summit-195879.html Newly branded merchant bank, Redfund Capital, will be part of an up-and-coming investor summit in Toronto next week.

The merchant bank, which will focus on the funding of companies, provides debt and equity funding instruments to cannabis companies that require project-specific funding. It will also provide services to cannabis-related companies to help them move towards being publicly listed.

The upcoming summit comprises leader market movers in the marijuana, battery materials and blockchain sub-sectors. There will be more than two dozen company presentations and a range of panels, with experts from around the world.

READ: ‘Cannabis 2.0 is here’: Redfund Capital fires up to serve maturing cannabis market

The InvestorIntel Summits were initially coordinated for the critical materials market and have grown to be a source of rising market stars in Australia, Canada and the United States," said InvestorIntel CEO Tracy Weslosky.

"I loved what our Johannesburg based analyst Lara Smith wrote last week when she wrote, ‘In a time of constant political, social and technological upheaval, new markets are birthed more frequently than ever before; the Buds, Batteries  and  Blockchain  event  quite  rightly  highlights  the  three  major  interest  segments  that  overwhelm  the retail investment landscape today.’ And Redfund Capital is an example of a company that is inevitably in the right place at the right time.”

READ: Redfund Capital signs up second client

The company – designed by bankers and entrepreneurs – provides both debt and equity financing to companies to allow them to expand, without prematurely releasing equity early in the growth cycle.

"We have assembled an amazing team of banking industry experts positioned to build Redfund into a formidable merchant bank focused on the quickly maturing cannabis industry," said chief executive officer, Meris Kott. 

"Cannabis 2.0 is here. Our clients are innovative, responsive and already successful and revenue generating. We are not country focused and are looking internationally to work with cannabis trailblazers."

]]>
Thu, 26 Apr 2018 09:42:00 -0400 https://www.proactiveinvestors.com/companies/news/195879/buds-batteries-and-blockchain-redfund-to-showcase-at-toronto-investor-summit-195879.html
<![CDATA[News - ‘Cannabis 2.0 is here’: Redfund Capital fires up to serve maturing cannabis market ]]> https://www.proactiveinvestors.com/companies/news/195683/cannabis-20-is-here-redfund-capital-fires-up-to-serve-maturing-cannabis-market-195683.html Booming. Evolving. Complicated. Three words that aptly describe the Canadian cannabis market.

Redfund Capital is positioning itself to jump headfirst into that market, and beyond. 

The goal? To help solve one of the most significant obstacles faced by cannabis related businesses: accessing much-needed funds to succeed in a rapidly changing market.

READ: Redfund Capital to finance expansion plans of medicinal cannabis cultivator, RxMM Health Capital

The merchant bank, which will focus on the funding of companies operating in the cannabis sector, reversed into Parana Copper Corp, with the Canadian Stock Exchange (CSE) approving the company’s proposed change of business.

It provides debt and equity funding instruments to cannabis companies that require project-specific funding. It will also provide services to companies, to help them move towards being publicly listed.

“We have assembled an amazing team of banking industry experts positioned to build Redfund into a formidable merchant bank focused on the quickly maturing cannabis industry,” said chief executive officer, Meris Kott.

“Cannabis 2.0 is here. Our clients are innovative, responsive and already revenue generating.”

Equity-type financing the norm, debt-financing harder to find

The company – designed by bankers and entrepreneurs – provides both debt and equity financing to companies to allow them to expand, without prematurely releasing equity early in the growth cycle.

Kott says that many companies face challenges when it comes to the types of financing available to them.

"We have designed a company with a debt facility to provide bridge financing to companies who are starting to build their revenues and have low valuations, so they don't give up equity prematurely before they are ready."

Redfund's investments will be deployed to companies that have demonstrated success in the cannabis industry.

“Redfund is committed to project specific funding solutions providing a steady growth avenue for our shareholders,” added Kott.

Kott has spent 25 years building global bridges for public companies. Her experience is widespread, with a focus on targeting companies for investment and acquisition purposes for large multinational corporations. She has been involved in cannabis since Amendment 64 launched in Colorado in 2012.

Legalization on the horizon

Devising effective equity/debt financing strategies will undoubtedly be beneficial for backers and the Canadian cannabis industry overall.

Canada is on the doorstep of a multi-billion industry, and there is tremendous opportunity for debt/equity financiers to capitalize on early market participants seeking funding to help expand.

With legalization on the horizon (reportedly summer 2018), customers will soon be able to buy from government-approved dealers. 

Recreational pot sales in Canada are forecast to reach C$6bln by 2021, with the medical marijuana market estimated to reach C$1.3bln.

Indeed, since the 2015 federal election in Canada, over C$1.8bln has been raised through equity offerings and the industry market cap now exceeds C$24bln.

Redfund signs agreement with RxMM

Medicinal cannabis cultivator RxMM Health Capital has signed on with Redfund as its first project. The British Columbia based company intends to list on the CSE and the US OTC exchange.

“We are excited to welcome RxMM as our first medical cannabis project. In the next few weeks we are expecting to fund their company and help fuel their expansion plans, and commence our trading on the CSE,” said Kott.

RxMM has signed a two-year financing facility with Redfund in the form of a promissory note. Interest will be compounded and paid monthly and Redfund has right of first refusal on financings to RxMM. Redfund has a right of first refusal on financings to RxMM.

Looking beyond borders

But Redfund is also looking beyond the Canadian border.

One such country is Colombia, where medicinal cannabis is legal, and has allowed the country to become a global player, while fostering an environment for the country to become a significant player in the international market.

READ: Redfund Capital signs up second client

Redfund recently signed up Biominerales Pharma Corp as a client. Biominerales has been granted global extraction and exportation licenses for medicinal cannabis oil.

Colombia has excellent year-round growing conditions and long history of a strong agriculture industry.

According to Kott, the Canadian public markets have embraced Colombia as one of the few South American countries with completed legislation and cannabis licenses granted. 

"As we expand our clientele, our goal is to work with companies who have revenues and have shown they are leaders in the cannabis industry globally," said Kott. "BMP’s cannabis licenses, ability to export globally, near term revenues on their cultivation, make them an immediate leader in Colombia."

]]>
Tue, 24 Apr 2018 13:39:00 -0400 https://www.proactiveinvestors.com/companies/news/195683/cannabis-20-is-here-redfund-capital-fires-up-to-serve-maturing-cannabis-market-195683.html
<![CDATA[News - Redfund Capital signs up second client ]]> https://www.proactiveinvestors.com/companies/news/195667/redfund-capital-signs-up-second-client-195667.html Parana Copper Corporation (CNSX:COPR), soon to change its name to Redfund Capital Corp, has signed up Biominerales Pharma Corp as a client.

Redfund, a merchant bank focused on the cannabis industry, said Colombian firm Biominerales has been granted global extraction and exportation licenses for medicinal cannabis oil.

READ: Redfund Capital to finance expansion plans of medicinal cannabis cultivator, RxMM Health Capital​

The client win follows just four days after Redfund announced its first client, RxMM Health Capital.

The Biominerales (BMP) team is located in offices in Bogota and currently partners with 180 experienced cultivators, chemical engineers, agronomists and top local and international doctors. The first crop of cannabis is set to be harvested in late August 2018.

“As we expand our clientèle, our goal is to work with companies who have revenue and have shown they are leaders in the cannabis industry," said Meris Kott, the chief executive officer of Redfund.

“BMP’s cannabis licenses, ability to export globally, near-term revenues on their cultivation, make them an immediate leader in Colombia. There has been much hearsay on companies in the country that we are pleased to be partnering with a successful entity with an already established footprint,” she added.

]]>
Tue, 24 Apr 2018 08:04:00 -0400 https://www.proactiveinvestors.com/companies/news/195667/redfund-capital-signs-up-second-client-195667.html
<![CDATA[News - Redfund Capital to finance expansion plans of medicinal cannabis cultivator, RxMM Health Capital ]]> https://www.proactiveinvestors.com/companies/news/195505/redfund-capital-to-finance-expansion-plans-of-medicinal-cannabis-cultivator-rxmm-health-capital-195505.html Redfund Capital, the merchant bank focused on the cannabis industry, has announced medicinal cannabis cultivator RxMM Health Capital as its first medical cannabis project.

RxMM is a British Columbia based company that intends to float on the Canadian Stock Exchange (CSE) and the US OTC exchange.

It has signed a two-year financing facility with Redfund in the form of a promissory note. Interest will be compounded and paid monthly.

Redfund has a right of first refusal on financings to RxMM.

“We are excited to welcome RxMM as our first medical cannabis project. In the next few weeks we are expecting to fund their company and help fuel their expansion plans, and commence our trading on the CSE,” said Meris Kott, the chief executive officer of Redfund.

As previously disclosed, Redfund Capital Group has reversed into Parana Copper Corp and the CSE has approved the company’s proposed change of business.

A date for the resumption of trading in the shares will be determined upon confirmation of the completion of a private placement, as well as completion of the usual application documentation and fees pursuant to CSE policies.

The company has tweaked the details of its private placement to raise up to C$35mln through the issue of units at C$0.35 a pop.

Each unit will now consist of one common share and one warrant entitling the holder to subscribe for one common share for $0.60 for a period of up to two years, subject to Redfund having the right to accelerate the expiry date if the shares trade at $0.90 for a period of 14 consecutive days, which can include days where no shares trade.

Proceeds of the private placement will be used to pay for the costs of the transaction, working capital and to provide loans to customers of the cannabis merchant bank Redfund Capital Corp.

]]>
Fri, 20 Apr 2018 14:53:00 -0400 https://www.proactiveinvestors.com/companies/news/195505/redfund-capital-to-finance-expansion-plans-of-medicinal-cannabis-cultivator-rxmm-health-capital-195505.html